![AMPH - Amphastar Pharmaceuticals Inc - Stock Price Chart]() |
Market Cap | 1.09B | EPS (ttm) | 2.76 |
P/E | 8.42 | EPS this Y | -19.13% |
Forward P/E | 6.61 | EPS next Y | 12.49% |
PEG | - | EPS past 5Y | 25.59% |
P/S | 1.50 | EPS next 5Y | -1.31% |
P/B | 1.47 | EPS Q/Q | -37.78% |
Dividend | - | Sales Q/Q | -0.76% |
Insider Own | 26.64% | Inst Own | 72.39% |
Insider Trans | -0.06% | Inst Trans | -5.07% |
Short Float | 11.80% | Earnings | May 07/a |
Analyst Recom | 2.33 | Target Price | 32.40 |
Avg Volume | 564.86K | 52W Range | 22.64 - 53.96 |
|
|
|
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Petersen Floyd F. | Director | Jul 02 '25 | Sale | 23.47 | 500 | 11,734 | 77,531 | Jul 03 05:30 PM | Petersen Floyd F. | Director | Jul 02 '25 | Proposed Sale | 23.43 | 500 | 11,715 | | Jul 02 04:01 PM | Zhang Jack Y. | CEO & CHIEF SCIENTIFIC OFFICER | Jun 13 '25 | Option Exercise | 13.03 | 200,000 | 2,606,000 | 2,847,659 | Jun 16 05:19 PM | Petersen Floyd F. | Director | Jun 02 '25 | Sale | 25.67 | 500 | 12,835 | 72,909 | Jun 04 06:39 PM | Petersen Floyd F. | Director | Jun 02 '25 | Proposed Sale | 25.61 | 500 | 12,805 | | Jun 02 04:06 PM |
|
|
 |
![BEAM - Beam Therapeutics Inc - Stock Price Chart]() |
Market Cap | 2.01B | EPS (ttm) | -4.61 |
P/E | - | EPS this Y | -0.41% |
Forward P/E | - | EPS next Y | -0.84% |
PEG | - | EPS past 5Y | -20.88% |
P/S | 31.65 | EPS next 5Y | -0.84% |
P/B | 1.79 | EPS Q/Q | -2.85% |
Dividend | - | Sales Q/Q | 0.81% |
Insider Own | 10.88% | Inst Own | 88.21% |
Insider Trans | -1.15% | Inst Trans | 28.25% |
Short Float | 24.21% | Earnings | May 06/b |
Analyst Recom | 1.39 | Target Price | 43.44 |
Avg Volume | 2.19M | 52W Range | 13.52 - 35.25 |
|
|
|
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Simon Amy | Chief Medical Officer | Jul 03 '25 | Sale | 20.12 | 876 | 17,625 | 64,864 | Jul 03 05:30 PM | Simon Amy | Chief Medical Officer | Jul 01 '25 | Sale | 16.94 | 374 | 6,336 | 65,740 | Jul 03 05:30 PM | Bellon Christine | Chief Legal Officer | Apr 01 '25 | Sale | 18.35 | 5,674 | 104,122 | 117,294 | Apr 03 09:53 PM | Evans John M. | CEO | Apr 01 '25 | Sale | 18.35 | 30,663 | 562,684 | 986,249 | Apr 03 09:52 PM | Ciaramella Giuseppe | President | Apr 01 '25 | Sale | 18.35 | 7,434 | 136,418 | 190,216 | Apr 03 09:51 PM |
|
|
 |
![SHAK - Shake Shack Inc - Stock Price Chart]() |
Market Cap | 6.06B | EPS (ttm) | 0.29 |
P/E | 494.08 | EPS this Y | 44.47% |
Forward P/E | 85.03 | EPS next Y | 25.61% |
PEG | 15.55 | EPS past 5Y | -17.79% |
P/S | 4.72 | EPS next 5Y | 31.77% |
P/B | 12.06 | EPS Q/Q | 105.26% |
Dividend | - | Sales Q/Q | 10.46% |
Insider Own | 4.82% | Inst Own | 103.41% |
Insider Trans | -3.50% | Inst Trans | 4.70% |
Short Float | 14.67% | Earnings | May 01/b |
Analyst Recom | 2.38 | Target Price | 123.81 |
Avg Volume | 1.51M | 52W Range | 72.93 - 141.65 |
|
|
|
Shake Shack, Inc. engages in the operation and licensing of Shake Shack restaurants which serve burgers, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and related products. The company was founded by Daniel Harris Meyer on September 23, 2014 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Meyer Daniel Harris | Director | Jul 01 '25 | Sale | 139.03 | 15,800 | 2,196,673 | 352,184 | Jul 03 05:23 PM | Meyer Daniel Harris | Director | Jul 02 '25 | Sale | 140.31 | 14,200 | 1,992,455 | 337,984 | Jul 03 05:23 PM | Meyer Daniel Harris | Director | Jun 26 '25 | Sale | 140.07 | 20,000 | 2,801,344 | 367,984 | Jun 30 04:49 PM | Fogertey Katherine Irene | Chief Financial Officer | Jun 12 '25 | Sale | 127.49 | 3,956 | 504,363 | 35,750 | Jun 16 05:07 PM | Fogertey Katherine Irene | Chief Financial Officer | Jun 13 '25 | Sale | 124.84 | 562 | 70,161 | 35,188 | Jun 16 05:07 PM |
|
|
|  |
![XYZ - Block Inc - Stock Price Chart]() |
Market Cap | 42.58B | EPS (ttm) | 4.11 |
P/E | 16.84 | EPS this Y | -19.82% |
Forward P/E | 18.87 | EPS next Y | 35.75% |
PEG | 1.56 | EPS past 5Y | 41.45% |
P/S | 1.78 | EPS next 5Y | 10.80% |
P/B | 1.99 | EPS Q/Q | -59.33% |
Dividend | - | Sales Q/Q | -3.11% |
Insider Own | 12.84% | Inst Own | 63.69% |
Insider Trans | -0.15% | Inst Trans | 1.14% |
Short Float | 4.02% | Earnings | May 01/a |
Analyst Recom | 1.87 | Target Price | 67.70 |
Avg Volume | 9.61M | 52W Range | 44.27 - 99.26 |
|
|
Jul-02-25 | Initiated |
Compass Point |
Buy |
$80 |
|
|
Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the Square and Cash App segments. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. It also includes Cash App Card, which is linked to customer stored balances that customers can use to pay for purchases or withdraw funds from an ATM. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Owen Britton Jennings | Officer | Jul 02 '25 | Proposed Sale | 69.26 | 1,050 | 72,723 | | Jul 03 05:18 PM | Brian Grassadonia | Officer | Jul 02 '25 | Proposed Sale | 69.26 | 1,342 | 92,947 | | Jul 03 05:18 PM | Chrysty Esperanza | Officer | Jul 02 '25 | Proposed Sale | 69.26 | 406 | 28,120 | | Jul 03 05:18 PM | Ajmere Dale | Officer | Jul 02 '25 | Proposed Sale | 69.26 | 366 | 25,349 | | Jul 03 05:17 PM | Amrita Ahuja | Officer | Jul 02 '25 | Proposed Sale | 69.26 | 1,351 | 93,571 | | Jul 03 05:17 PM |
|
|
 |
![RYTM - Rhythm Pharmaceuticals Inc - Stock Price Chart]() |
Market Cap | 4.18B | EPS (ttm) | -2.82 |
P/E | - | EPS this Y | 37.85% |
Forward P/E | - | EPS next Y | 48.72% |
PEG | - | EPS past 5Y | -2.34% |
P/S | 30.57 | EPS next 5Y | - |
P/B | 220.41 | EPS Q/Q | 65.72% |
Dividend | - | Sales Q/Q | 25.94% |
Insider Own | 8.53% | Inst Own | 95.47% |
Insider Trans | -5.44% | Inst Trans | 0.04% |
Short Float | 8.17% | Earnings | May 07/b |
Analyst Recom | 1.00 | Target Price | 83.42 |
Avg Volume | 739.33K | 52W Range | 40.46 - 69.89 |
|
|
|
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Garfield Alastair | Chief Scientific Officer | Jul 02 '25 | Sale | 64.81 | 1,319 | 85,483 | 3,126 | Jul 03 05:12 PM | German Christopher Paul | Corporate Controller & CAO | Jun 10 '25 | Option Exercise | 17.97 | 1,069 | 19,210 | 3,958 | Jun 12 04:50 PM | German Christopher Paul | Corporate Controller & CAO | Jun 10 '25 | Sale | 67.19 | 2,069 | 139,016 | 1,889 | Jun 12 04:50 PM | Cramer Pamela J. | Chief Human Resources Officer | Jun 06 '25 | Option Exercise | 6.80 | 7,031 | 47,811 | 26,240 | Jun 10 04:45 PM | Cramer Pamela J. | Chief Human Resources Officer | Jun 06 '25 | Sale | 68.05 | 7,031 | 478,435 | 19,209 | Jun 10 04:45 PM |
|
|
|  |
![PEGA - Pegasystems Inc - Stock Price Chart]() |
Market Cap | 9.25B | EPS (ttm) | 1.03 |
P/E | 52.54 | EPS this Y | 26.95% |
Forward P/E | 27.09 | EPS next Y | 3.71% |
PEG | 4.00 | EPS past 5Y | - |
P/S | 5.63 | EPS next 5Y | 13.13% |
P/B | 15.13 | EPS Q/Q | 729.21% |
Dividend | 0.10% | Sales Q/Q | 44.07% |
Insider Own | 49.07% | Inst Own | 49.35% |
Insider Trans | -0.47% | Inst Trans | - |
Short Float | 5.74% | Earnings | Apr 22/a |
Analyst Recom | 1.62 | Target Price | 49.33 |
Avg Volume | 2.16M | 52W Range | 28.31 - 56.83 |
|
|
|
Pegasystems, Inc. engages in the development, market, license, and support of software, which allows organizations to build, deploy, and change enterprise applications. Its product, Pega Infinity, helps connect enterprises to their customers in real-time across channels, streamline business operations, and adapt to meet changing requirements. The company was founded by Alan Trefler in 1983 and is headquartered in Waltham, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
STILLWELL KENNETH | COO, CFO | Jul 01 '25 | Sale | 52.64 | 4,000 | 210,570 | 49,350 | Jul 03 05:10 PM | KENNETH STILLWELL | Officer | Jul 01 '25 | Proposed Sale | 54.13 | 4,000 | 216,520 | | Jul 01 04:33 PM | TREFLER ALAN | C.E.O. & Chairman | Jun 18 '25 | Sale | 100.83 | 31,500 | 3,176,003 | 17,027,892 | Jun 23 05:04 PM | TREFLER ALAN | C.E.O. & Chairman | Jun 17 '25 | Sale | 101.04 | 31,500 | 3,182,828 | 17,059,392 | Jun 18 05:02 PM | Higgins John Gerard | Chief, Client &Partner Success | Jun 12 '25 | Option Exercise | 33.90 | 40,000 | 1,356,000 | 59,013 | Jun 13 04:59 PM |
|
|
 |
![EA - Electronic Arts, Inc - Stock Price Chart]() |
Market Cap | 39.04B | EPS (ttm) | 4.24 |
P/E | 36.68 | EPS this Y | 17.74% |
Forward P/E | 17.29 | EPS next Y | 10.38% |
PEG | 2.85 | EPS past 5Y | -16.24% |
P/S | 5.24 | EPS next 5Y | 12.86% |
P/B | 6.14 | EPS Q/Q | 45.48% |
Dividend | 0.42% | Sales Q/Q | 5.97% |
Insider Own | 9.74% | Inst Own | 88.55% |
Insider Trans | -0.28% | Inst Trans | -3.21% |
Short Float | 4.62% | Earnings | May 06/a |
Analyst Recom | 2.29 | Target Price | 170.70 |
Avg Volume | 3.22M | 52W Range | 115.21 - 168.50 |
|
|
|
Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Singh Vijayanthimala | Chief People Officer | Jul 01 '25 | Sale | 159.53 | 1,000 | 159,530 | 37,131 | Jul 03 05:06 PM | Miele Laura | President of EA Entertainment | Jul 01 '25 | Sale | 159.50 | 2,500 | 398,744 | 60,592 | Jul 03 05:05 PM | Singh-Force Family Trust | Officer | Jul 01 '25 | Proposed Sale | 159.70 | 1,000 | 159,700 | | Jul 01 04:33 PM | Wilson Andrew | Chairman & CEO | Jun 20 '25 | Sale | 150.64 | 5,000 | 753,215 | 62,393 | Jun 23 06:06 PM | Schatz Jacob J. | EVP, Global Affairs and CLO | Jun 16 '25 | Sale | 148.69 | 1,500 | 223,035 | 29,948 | Jun 17 07:59 PM |
|
|
|  |
![CDNS - Cadence Design Systems, Inc - Stock Price Chart]() |
Market Cap | 89.23B | EPS (ttm) | 3.95 |
P/E | 82.77 | EPS this Y | 13.41% |
Forward P/E | 42.07 | EPS next Y | 14.74% |
PEG | 5.83 | EPS past 5Y | 1.80% |
P/S | 18.31 | EPS next 5Y | 14.19% |
P/B | 18.68 | EPS Q/Q | 10.44% |
Dividend | - | Sales Q/Q | 23.12% |
Insider Own | 0.56% | Inst Own | 88.50% |
Insider Trans | -9.38% | Inst Trans | 0.71% |
Short Float | 1.36% | Earnings | Apr 28/a |
Analyst Recom | 1.72 | Target Price | 323.24 |
Avg Volume | 2.13M | 52W Range | 221.56 - 326.19 |
|
|
|
Cadence Design Systems, Inc. engages in the provision of design and development of integrated circuits and electronic devices. It operates through the following geographical segments: Americas, Asia, EMEA, and Japan. The company was founded by Alberto Sangiovanni-Vincentelli, Gudmundur A. Hjartarson, K. Bobby Chao, and K. Charles Janac in June 1988 and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cunningham Paul | Sr. Vice President | Jul 01 '25 | Sale | 306.35 | 1,000 | 306,350 | 105,499 | Jul 03 05:06 PM | PAUL A CUNNINGHAM | Officer | Jul 01 '25 | Proposed Sale | 306.35 | 1,000 | 306,350 | | Jul 01 04:20 PM | TENG CHIN-CHI | Sr. Vice President | Jun 17 '25 | Option Exercise | 142.50 | 5,392 | 768,360 | 141,605 | Jun 20 05:09 PM | TENG CHIN-CHI | Sr. Vice President | Jun 17 '25 | Sale | 300.92 | 8,892 | 2,675,799 | 136,213 | Jun 20 05:09 PM | Cunningham Paul | Sr. Vice President | Jun 13 '25 | Sale | 302.00 | 1,000 | 302,000 | 106,499 | Jun 17 05:48 PM |
|
|
 |
![WRBY - Warby Parker Inc - Stock Price Chart]() |
Market Cap | 2.70B | EPS (ttm) | -0.12 |
P/E | - | EPS this Y | 2.18% |
Forward P/E | 51.26 | EPS next Y | 38.35% |
PEG | - | EPS past 5Y | 19.99% |
P/S | 3.40 | EPS next 5Y | 17.42% |
P/B | 7.63 | EPS Q/Q | 224.00% |
Dividend | - | Sales Q/Q | 11.89% |
Insider Own | 19.39% | Inst Own | 78.61% |
Insider Trans | -4.85% | Inst Trans | -3.12% |
Short Float | 10.25% | Earnings | May 08/b |
Analyst Recom | 1.94 | Target Price | 22.14 |
Avg Volume | 2.73M | 52W Range | 12.46 - 28.68 |
|
|
|
Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gilboa David Abraham | Co-Chief Executive Officer | Jul 01 '25 | Sale | 22.04 | 50,000 | 1,102,000 | 28,475 | Jul 03 05:00 PM | David Gilboa | Director | Jul 01 '25 | Proposed Sale | 21.93 | 50,000 | 1,096,500 | | Jul 01 04:32 PM | Gilboa David Abraham | Co-Chief Executive Officer | Jun 03 '25 | Option Exercise | 0.00 | 9,816 | 0 | 33,905 | Jun 05 08:23 PM | Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 03 '25 | Option Exercise | 0.00 | 9,816 | 0 | 33,777 | Jun 05 08:22 PM | Miller Steven Clive | Chief Financial Officer | Jun 03 '25 | Option Exercise | 0.00 | 30,175 | 0 | 237,092 | Jun 05 08:21 PM |
|
|
 |
![VENU - Venu Holding Corp - Stock Price Chart]() |
Market Cap | 484.75M | EPS (ttm) | -0.87 |
P/E | - | EPS this Y | 17.83% |
Forward P/E | 28.63 | EPS next Y | 163.21% |
PEG | - | EPS past 5Y | - |
P/S | 27.88 | EPS next 5Y | - |
P/B | 6.14 | EPS Q/Q | -15.35% |
Dividend | - | Sales Q/Q | -11.18% |
Insider Own | 31.04% | Inst Own | 3.11% |
Insider Trans | -0.82% | Inst Trans | 176.08% |
Short Float | 0.09% | Earnings | May 15/a |
Analyst Recom | 1.00 | Target Price | 14.17 |
Avg Volume | 73.50K | 52W Range | 7.05 - 14.75 |
|
|
|
Venu Holding Corp. designs, develops, owns, and operates up-scale music venues, outdoor amphitheaters, and restaurants. It offers entertainment and hospitality services. It operates through its single segment, the restaurant and event center operations. The company was founded by Jay W. Roth on March 13, 2017 and is headquartered in Colorado Springs, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Atkinson Heather | Chief Financial Officer | Jul 01 '25 | Sale | 12.22 | 414 | 5,059 | 145,432 | Jul 03 05:00 PM | Atkinson Heather | Chief Financial Officer | Jul 02 '25 | Sale | 12.39 | 256 | 3,172 | 145,176 | Jul 03 05:00 PM | ROTH JAY W | CEO & Chairman | Jul 01 '25 | Sale | 12.22 | 8,201 | 100,216 | 9,273,101 | Jul 03 05:00 PM | ROTH JAY W | CEO & Chairman | Jul 02 '25 | Sale | 12.39 | 5,073 | 62,854 | 9,268,028 | Jul 03 05:00 PM | ROTH JAY W | CEO & Chairman | Jul 01 '25 | Sale | 12.22 | 2,233 | 27,287 | 1,007,468 | Jul 03 05:00 PM |
|
|
|